Market Tracker

10/20 5:16pm ET

ImmunoGen Inc (NASDAQ:IMGN)

5.86
Delayed Data
As of Oct 20
 -0.31 / -5.02%
Today’s Change
1.51
Today|||52-Week Range
8.84
+187.25%
Year-to-Date

Today’s Trading

Previous close6.17
Today’s open6.19
Day’s range5.84 - 6.21
Volume3,262,442
Average volume (3 months)3,667,638
Market cap$657.6M
Dividend yield--
Data as of 4:00pm ET, 10/20/2017

Growth & Valuation

Earnings growth (last year)-154.93%
Earnings growth (this year)+50.82%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)-49.72%
P/E ratioNM
Price/Sales4.13
Price/Book--

Competitors

 Today’s
change
Today’s
% change
CHRSCoherus BioSciences ...-0.20-1.44%
NTLAIntellia Therapeutic...+0.17+0.61%
MYOVMyovant Sciences Ltd+0.38+2.81%
CRSPCRISPR Therapeutics ...+0.10+0.53%
Data as of 4:02pm ET, 10/20/2017

Financials

Next reporting dateOctober 27, 2017
EPS forecast (this quarter)-$0.26
Annual revenue (last year)$43.0M
Annual profit (last year)-$157.8M
Net profit margin-366.80%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mark J. Enyedy
Chief Financial Officer &
Executive Vice President
David B. Johnston
Corporate headquarters
Waltham, Massachusetts

Forecasts